Xtant Medical Holdings, Inc. XTNT
Medical/Dental Instruments · data as of November 13, 2026
Xtant Medical Holdings, Inc. (XTNT) is a healthcare company listed in the US with a market value of about $38M. In the twelve months to June 30, 2026 it had revenue of $110M and net income of -$11M, a net margin of -10.2%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (1/5).
Key numbers: 5-year revenue growth of 20% a year, a 5-year average ROIC of -7%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 99% above the current price.
About Xtant Medical
Xtant Medical is listed in the US and classified in medical/dental instruments. Revenue went from $35M in 2014 to $134M in 2025, growth of about 12.9% a year. It was profitable in 2 of the last 10 years in our data. Its share count rose by 59% over three years (dilution for shareholders). It spends 2% of revenue on research and development.
Score: 1.6 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $110M | $134M | $117M | $91M | $58M | $55M | $53M | $65M | $72M | $83M | $90M |
| Net income | -$11M | $5M | -$16M | $660000 | -$8M | -$5M | -$7M | -$8M | -$70M | -$52M | -$19M |
| Free cash flow | -$696000 | $10M | -$16M | -$11M | -$7M | -$2M | -$2M | -$1M | $588000 | -$2M | -$20M |
| EPS (diluted) | $-0.08 | $0.03 | $-0.12 | $0.01 | $-0.09 | $-0.06 | $-0.25 | $-0.63 | $-5.97 | $-34.76 | $-18.46 |
| Net margin | -10.2% | 3.7% | -14.0% | 0.7% | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% |
| ROIC | — | 7.5% | -12.2% | -10.7% | -11.2% | -6.4% | -1.8% | -5.2% | -138.9% | -47.7% | -5.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Xtant Medical stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 99% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Xtant Medical pay a dividend?
Not currently.
Is Xtant Medical a good stock to buy?
We do not give buy or sell advice. Xtant Medical scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.